UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Development and Clinical Evaluation of an Artificial Intelligence Support Tool for Improving Telemedicine Photo Quality

JAMA dermatology (Chicago, Ill.), 2023-05, Vol.159 (5), p.496

2023

Volltextzugriff (PDF)

Distinguishing malignant from benign microscopic skin lesions using desorption electrospray ionization mass spectrometry imaging

Proceedings of the National Academy of Sciences - PNAS, 2018-06, Vol.115 (25), p.6347-6352

2018

Volltextzugriff (PDF)

Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa

Orphanet journal of rare diseases, 2022-10, Vol.17 (1), p.1-377, Article 377

2022

Volltextzugriff (PDF)

Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa

JCI insight, 2019-10, Vol.4 (19)

2019

Volltextzugriff (PDF)

A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex

Orphanet journal of rare diseases, 2022-07, Vol.17 (1), p.1-270, Article 270

2022

Volltextzugriff (PDF)

Adult-onset inflammatory linear verrucous epidermal nevus successfully treated with intralesional steroid

JAAD Case Reports, 2024-04, Vol.46, p.5-7

2024

Volltextzugriff (PDF)

Association between yearlong air pollution and moderate-severe atopic dermatitis: A United States cross-sectional claims analysis

JAAD international, 2023-12, Vol.13, p.4-6

2023

Volltextzugriff (PDF)

Development of a digital tool for home-based monitoring of skin disease for older adults

Skin health and disease, 2023-10, Vol.3 (5), p.e235-e235

2023

Volltextzugriff (PDF)

Dupilumab for occupational irritant hand dermatitis in a nonatopic individual: A case report

JAAD Case Reports, 2020-04, Vol.6 (4), p.296-298

2020

Volltextzugriff (PDF)

Histopathologic correlation of skin manifestations of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection

JAAD Case Reports, 2021-10, Vol.16, p.108-109

2021

Volltextzugriff (PDF)

Bridging to a selective Janus kinase 1 inhibitor in severe atopic dermatitis: An instructive case with upadacitinib

JAAD Case Reports, 2021-01, Vol.7, p.65-67

2021

Volltextzugriff (PDF)

Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials

JAMA dermatology (Chicago, Ill.), 2022-04, Vol.158 (4), p.404

2022

Volltextzugriff (PDF)

Localized bullous pemphigoid in a melanoma patient with dual exposure to PD-1 checkpoint inhibition and radiation therapy

JAAD Case Reports, 2017-09, Vol.3 (5), p.404-406

2017

Volltextzugriff (PDF)

Noninvasive Detection of Skin Cancer by Imprint Desorption Electrospray Ionization Mass Spectrometry Imaging

Analytical chemistry (Washington), 2024-01, Vol.96 (1), p.28-32

2024

Volltextzugriff (PDF)

Improved sleep parallels improvements in atopic dermatitis signs, symptoms, and quality of life in adult patients treated with dupilumab: 24-week results from the DUPISTAD study

Journal of the American Academy of Dermatology, 2024-07

2024

Volltextzugriff (PDF)

Evaluation of diagnosis diversity in artificial intelligence datasets: a scoping review

British journal of dermatology (1951), 2023-02, Vol.188 (2), p.292-294

2023

Volltextzugriff (PDF)

Phase 2 trial of a neurokinin-1 receptor antagonist for the treatment of chronic itch in patients with epidermolysis bullosa: A randomized clinical trial

Journal of the American Academy of Dermatology, 2020-06, Vol.82 (6), p.1415-1421

2020

Volltextzugriff (PDF)

Asymptomatic, microscopic hematuria in epidermolysis bullosa: A single center retrospective case series

Journal of the American Academy of Dermatology, 2022-12, Vol.87 (6), p.1419-1421

2022

Volltextzugriff (PDF)

Prevalence of potentially allergenic ingredients in products labeled for eczema care

Journal of the American Academy of Dermatology, 2022-06, Vol.86 (6), p.1379-1381

2022

Volltextzugriff (PDF)

Disparities in dermatology AI performance on a diverse, curated clinical image set

Science advances, 2022-08, Vol.8 (32), p.eabq6147-eabq6147

2022

Volltextzugriff (PDF)

A qualitative exploration of the experiences of itch for adults living with epidermolysis bullosa

British journal of dermatology (1951), 2022-08, Vol.187 (2), p.261-263

2022

Volltextzugriff (PDF)

Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study

British journal of dermatology (1951), 2023-11, Vol.189 (6), p.685-694

2023

Volltextzugriff (PDF)

Dupilumab treatment of nummular dermatitis: A retrospective cohort study

Journal of the American Academy of Dermatology, 2020-05, Vol.82 (5), p.1252-1255

2020

Volltextzugriff (PDF)

Evaluation of antipruritic effects of serlopitant, a neurokinin 1 receptor antagonist, in patients with epidermolysis bullosa: A phase 2 randomized controlled trial

Journal of the European Academy of Dermatology and Venereology, 2024-07

2024

Volltextzugriff (PDF)

Advanced aging skin and itch: addressing an unmet need

Dermatologic therapy, 2013-03, Vol.26 (2), p.92-103

2013

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Englisch
(100)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Life Sciences & Biomedicine
(34)
Humans
(23)
Dermatology
(16)
Technology
(13)
Male
(12)
Engineering
(11)
Adult
(10)
Female
(10)
Aged
(9)
Engineering, Electrical & Electronic
(9)
Middle Aged
(9)
Physical Sciences
(8)
Case Report
(6)
Chemistry
(6)
Epidermolysis Bullosa
(6)
Medicine, Research & Experimental
(6)
Research & Experimental Medicine
(6)
Skin Diseases
(6)
Adolescent
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Development and Clinical Evaluation of an Artificial Intelligence Support Tool for Improving Telemedicine Photo Quality

Distinguishing malignant from benign microscopic skin lesions using desorption electrospray ionization mass spectrometry imaging

Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa

Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa

A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex

Adult-onset inflammatory linear verrucous epidermal nevus successfully treated with intralesional steroid

Association between yearlong air pollution and moderate-severe atopic dermatitis: A United States cross-sectional claims analysis

Development of a digital tool for home-based monitoring of skin disease for older adults

Dupilumab for occupational irritant hand dermatitis in a nonatopic individual: A case report

Histopathologic correlation of skin manifestations of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection

Bridging to a selective Janus kinase 1 inhibitor in severe atopic dermatitis: An instructive case with upadacitinib

Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials

Localized bullous pemphigoid in a melanoma patient with dual exposure to PD-1 checkpoint inhibition and radiation therapy

Noninvasive Detection of Skin Cancer by Imprint Desorption Electrospray Ionization Mass Spectrometry Imaging

Improved sleep parallels improvements in atopic dermatitis signs, symptoms, and quality of life in adult patients treated with dupilumab: 24-week results from the DUPISTAD study

Evaluation of diagnosis diversity in artificial intelligence datasets: a scoping review

Phase 2 trial of a neurokinin-1 receptor antagonist for the treatment of chronic itch in patients with epidermolysis bullosa: A randomized clinical trial

Asymptomatic, microscopic hematuria in epidermolysis bullosa: A single center retrospective case series

Prevalence of potentially allergenic ingredients in products labeled for eczema care

Disparities in dermatology AI performance on a diverse, curated clinical image set

A qualitative exploration of the experiences of itch for adults living with epidermolysis bullosa

Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study

Dupilumab treatment of nummular dermatitis: A retrospective cohort study

Evaluation of antipruritic effects of serlopitant, a neurokinin 1 receptor antagonist, in patients with epidermolysis bullosa: A phase 2 randomized controlled trial

Advanced aging skin and itch: addressing an unmet need

Suchergebnisse filtern